Obesity, diabetes combating device safe for treatment

A non-surgical and reversible device for people with Type 2 diabetes and obesity.

A non-surgical and reversible device for people with Type 2 diabetes and obesity is safe, effective and should be rolled out across the National Health Service (NHS), researchers say. The device — Endobarrier — is a reversible treatment that provides people with an alternative to drastic gastric bypass surgery. It prevents food from coming into contact with the first part of the small intestine, but without painful invasive surgery. Endobarrier consists of a 60-cm-long tube-like liner or sleeve that coats the inside of the small intestine, allowing food to pass through but not to be absorbed, which can be removed after a year. The procedure aims to kick-start a change in lifestyle and help people achieve better health, improve diabetes control as well as promote weight loss, the researchers said.

What is an Endobarrier

The device, Endobarrier, is a reversible treatment that provides people with an alternative to drastic gastric bypass surgery. It prevents food from coming into contact with the first part of the small intestine, but without painful invasive surgery. Endobarrier consists of a 60-cm-long tube-like liner or sleeve that coats the inside of the small intestine, allowing food to pass through but not to be absorbed, which can be removed after a year. Now you can treat your Type 2 diabetes and obesity with a device based medical treatment which is highly safe and serves the purpose of a total cure says a study. The treatment prevents food from coming into contact with the first part of the small intestine through a surgery. Participants reported considerable improvements in well-being, energy, and the ability to exercise, with around 94 per cent saying that they would recommend the service to their friends and family. For the study, presented at 2017 European Association for the Study of Diabetes (EASD) Annual Meeting in Portugal, the team investigated whether this new therapy could be translated into major clinical success by creating a small NHS Endobarrier service for people having difficulties managing their Type 2 diabetes and obesity.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.